http://www.unboundmedicine.com/medline/ebm/research/nilotinibUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19924121/full_citation/Clinical_Pharmacokinetics_of_the_BCR_ABL_Tyrosine_Kinase_Inhibitor_Nilotinib_Tanaka C, Yin OQ, Sethuraman V, et al. 
Clinical Pharmacokinetics of the BCR-ABL Tyrosine Kinase Inhibitor Nilotinib. [JOURNAL ARTICLE]
Clin Pharmacol Ther 2009 Nov 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19922818/full_citation/Extended_kinase_profile_and_properties_of_the_protein_kinase_inhibitor_Nilotinib_Manley PW, Drueckes P, Fendrich G, et al. 
Extended kinase profile and properties of the protein kinase inhibitor Nilotinib. [JOURNAL ARTICLE]
Biochim Biophys Acta 2009 Nov 13.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19920925/full_citation/Nilotinib:_optimal_therapy_for_patients_with_chronic_myeloid_leukemia_and_resistance_or_intolerance_to_imatinib_Swords R, Mahalingam D, Padmanabhan S, et al. 
Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:89-101.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19920910/full_citation/Development_and_targeted_use_of_nilotinib_in_chronic_myeloid_leukemia_Fava C, Kantarjian H, Cortes J, et al. 
Development and targeted use of nilotinib in chronic myeloid leukemia. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:233-243.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19920908/full_citation/Severe_toxicity_of_skin_rash_fever_and_diarrhea_associated_with_imatinib:_case_report_and_review_of_skin_toxicities_associated_with_tyrosine_kinase_inhibitors_Huang X, Patel S, Ahmed N, et al. 
Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors. [JOURNAL ARTICLE]
Drug Des Devel Ther 2009.:215-219.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19909541/full_citation/The_occurrence_and_management_of_fluid_retention_associated_with_TKI_therapy_in_CML_with_a_focus_on_dasatinib_Masiello D, Gorospe G, Yang AS 
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib. [JOURNAL ARTICLE]
J Hematol Oncol 2009 Nov 12; 2(1):46.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19904720/full_citation/High_performance_liquid_chromatography_with_solid_phase_extraction_for_the_quantitative_determination_of_nilotinib_in_human_plasma_Miura M, Takahashi N, Sawada KI 
High-performance liquid chromatography with solid-phase extraction for the quantitative determination of nilotinib in human plasma. [JOURNAL ARTICLE]
Biomed Chromatogr 2009 Nov 10.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19895503/full_citation/Structural_Analysis_of_DFG_in_and_DFG_out_Dual_Src_Abl_Inhibitors_Sharing_a_Common_Vinyl_Purine_Template_Zhou T, Commodore L, Huang WS, et al. 
Structural Analysis of DFG-in and DFG-out Dual Src-Abl Inhibitors Sharing a Common Vinyl Purine Template. [JOURNAL ARTICLE]
Chem Biol Drug Des 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890374/full_citation/A_comprehensive_target_selectivity_survey_of_the_BCR_ABL_kinase_inhibitor_INNO_406_by_kinase_profiling_and_chemical_proteomics_in_chronic_myeloid_leukemia_cells_Rix U, Remsing Rix LL, Terker AS, et al. 
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells. [JOURNAL ARTICLE]
Leukemia 2009 Nov 5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19883308/full_citation/Overcoming_resistance_in_chronic_myelogenous_leukemia_Cooper S, Giles FJ, Savona MR 
Overcoming resistance in chronic myelogenous leukemia. [Journal Article]
Leuk Lymphoma 2009 Nov; 50(11):1785-93.
Abstract | Full Citation | Find Related Articles